Pelvic inflammatory disease epidemiology: What do we know and what do we need to know?

Sexually Transmitted Infections

Volumn 76, Issue 2, 2000, Pages 80-87

  Simms, Ian ^a   Stephenson, J M ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIASIS; HEALTH CARE COST; HUMAN; INCIDENCE; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; COST OF ILLNESS; FEMALE; FORECASTING; GREAT BRITAIN; HUMANS; INCIDENCE; PELVIC INFLAMMATORY DISEASE; PREVALENCE; RESEARCH; RISK FACTORS;

EID: 0034019509     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.2.80     Document Type: Review

References (88)

1. 1 Pearce J. Pelvic inflammatory disease. BMJ 1990;300:1090-1.
2. 2 Department of Health. Summary and conclusions of CMO's Expert Advisory Group. London: DoH, 1998.
3. 3 Simms I, Hughes G, Catchpole M. Screening for Chlamydia trachomatis. BMJ 1998;317:680-1.
4. 4 Sweet R. Microbial etiology of pelvic inflammatory disease. In: Landers D, Sweet R, eds. Pelvic inflammatory disease. New York: Springer-Verlag, 1996.
5. 5 Eschenbach D, Hillier S, Critchlow C, et al. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 1988;158:819-28.
6. 6 Sweet RL. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995;20:S271-5.
7. 7 Brunham RC, Binns B, Guijon F, et al. Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis 1988;158:510-17.
8. 8 Woølner-Hanssen P, Paavonen J, Kiviat N, et al. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline. Otstet Gynecol 1988;71:595-600.
9. 9 Bevan C, Johal B, Mumtaz G, et al. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol 1995;102: 407-14.
10. 10 Weström L. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialised countries. Am J Obstet Gynecol 1980;138:880-92.
11. 11 Buchan H, Vessey M, Goldacre M, et al. Morbidity following pelvic inflammatory disease. Br J Obstet Gynaecol 1993; 100:558-62.
12. 12 Risch H, Howe G. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 1995;4:447-51.
13. 13 Cohen C, Brunham R. Pathogenesis of chlamydia induced pelvic inflammatory disease. Sex Transm Inf 1999;75:21-4.
14. 14 Toye B, Laferrière P, Claman P, et al. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis 1993;168:1236-40.
15. 15 Brunham R, Peeling R, Maclean I, et al. Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates. J Infect Dis 1992;165:1076-81.
16. 16 Paavonen J, Lehtinen M. Immunopathogenesis of chlamydial pelvic inflammatory disease: the role of heat-shock proteins. Infect Dis Obstet Gynecol 1994;2:105-10.
17. 17 Korn A, Landers D. Pelvic inflammatory disease and HIV-1 infection. In: Landers D, Sweet R, eds. Pelvic inflammatory disease. Pittsburgh: Springer, 1999.
18. 18 Stamm W, Guinan M, Johnson C, et al. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984;310: 545-9.
19. 19 Weström L. Sexually transmitted diseases and infertility. Sex Transm Dis 1994;21:S32-7.
20. 20 Swenson C, Schachter J. Infertility as a consequence of chlamydial infection of the upper genital tract in female mice. Sex Transm Dis 1984;11:64-7.
21. 21 Hillis S, Joesoef R, Marchbanks P, et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993;168:1503-9.
22. 22 Wølner-Hanssen P. Silent pelvic inflammatory disease: is it overstated? Obstet Gynecol 1995; 86:321-5.
23. 23 Howard M, Doherty J, Zimic-Vincentic M, et al. An epidemiologic study of a decrease in hospitalizations for pelvic inflammatory disease (PID) in two Canadian cities (1985-1995). Ninth International Symposium on Human Chlamydial Infection, Napa Valley, USA, 1998.
24. 24 Kamwendo F, Forslin L, Bodin L, et al. Decreasing incidences of gonorrhoea and chlamydia associated acute pelvic inflammatory disease. Sex Transm Dis 1996;23:384-91.
25. 25 Kamwendo F, Forslin L, Bodin L, et al. Programmes to reduce pelvic inflammatory disease - the Swedish experience. Lancet 1998;351:25-8.
26. 26 Simms I, Catchpole M, Brugha R, et al. Epidemiology of genital Chlamydia trachomatis in England and Wales. Genitourin Med 1996;73:122-6.
27. 27 Hiltunen-Back E, Rostila T, Kautiainen H, et al. Rapid decrease of endemic gonorrhea in Finland. Sex Transm Dis 1998;25:181-6.
28. 28 Hansson H, Danielsson D. Epidemiology of sexually transmitted diseases in the Scandinavian countries. Scand J Infect Dis 1982;32:149-56.
29. 29 Meirik O. Ectopic pregnancy during 1961-78 in Uppsala County, Sweden. Acta Obstet Gynaecol Scand 1981:60:545-8.
30. 30 Weström L. Decrease in incidence of women treated in hospital for acute salpingitis in Sweden. Genitourin Med 1988; 64:59-63.
31. 31 Eschenbach D, Harnisch J, Holmes K. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol 1977;128:838-50.
32. 32 Hughes G, Simms I, Rogers P, et al. New cases seen at genitourinary medicine clinics: England 1997. CDR Suppl 1998;8:S1-12.
33. 33 Robinson N, Beral V, Ashley J. Trends in pelvic inflammatory disease in England and Wales. J Epidemiol Commun Health 1981;35:265-70.
34. 34 Buchan H, Vessey M. Epidemiology and trends in hospital discharges for pelvic inflammatory disease in England, 1975 to 1985. Br J Obstet Gynaecol 1989;96:1219-23.
35. 35 Adler M. Trends for gonorrhea and pelvic inflammatory disease in England and Wales and for gonorrhea in a defined population. Am J Obstet Gynecol 1980;138:901-4.
36. 36 Department of Health. Hospital episode statistics. London: HMSO, 1994.
37. 37 Simms I, Rogers P, Nicoll A. The influence of demographic change and cumulative risk of pelvic inflammatory disease on the incidence of ectopic pregnancy. Epidem Infect 1997; 119:49-52.
38. 38 Simms I, Rogers P, Charlett A. The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales. Int J STD AIDS 1999;10: 448-51.
39. 39 OPCS. Morbidity statistics from general practice: fourth national study, 1991-1992. London: HMSO, 1995.
40. 40 Washington A, Aral S, Wølner-Hanssen P, et al. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991;266:2581-6.
41. 41 Johnson A, Wadsworth J, Wellings K, et al. Sexual attitudes and lifestyles. Oxford: Blackwell Scientific, 1994.
42. 42 Cates Jr W, Rolfs Jr R, Aral S. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev 1990;12:199-220.
43. 43 Vessey M, Doll R, Peto P. A long term follow-up study of women using different methods of contraception - an interim report. J Biosoc Sci 1976;8:373-426.
44. 44 Blackwell A, Thomas P, Wareham K, et al. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet 1993;342: 206-10.
45. 45 Marchbanks P, Lee N, Petersen H. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol 1990;162:639-44.
46. 46 Scholes D, Daling J, Stergachis A. Current cigarette smoking and risk of acute pelvic inflammatory disease. Am J Public Health 1992;82:1352-5.
47. 47 Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system: follow-up studies in normal subjects after cessation of smoking. Med J Aust 1983;2:425-9.
48. 48 Pasley J, Rank R, Hough AJ. Effects of various doses of estradiol on chlamydia genital infection in ovariectomixed guinea pigs. Sex Transm Dis 1985;12:8-13.
49. 49 Wølner-Hanssen P, Eschenbach D, Paavonen J. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraception use. JAMA 1990;263:54-9.
50. 50 Scholes D, Daling J, Stergachis A, et al. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol 1993;81:601-5.
51. 51 Forrest K, Washington A, Daling J, et al. Vaginal douching as a possible risk factor for pelvic inflammatory disease. J Natl Med Assoc 1989;81:159-65.
52. 52 Woølner-Hanssen P, Eschenbach D, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990;263:1936-41.
53. 53 World Bank. World development report 1993. Investing in health. World development indicators. New York: Oxford University Press, 1993.
54. 54 OPCS. Mortality statistics, cause: England and Wales, 1992. London: HMSO, 1992.
55. 55 School of Public Health UoL. Effective health care: the management of subfertility. Leeds: University of Leeds, 1992.
56. 56 Washington A, Katz P. Cost of and payment source for pelvic inflammatory disease. JAMA 1991;226:2565-9.
57. 57 Evans B, Catchpole M, Heptonstall M, et al. Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales. BMJ 1993;306:426-8.
58. 58 Coutinho R, Rijsdijk A, van den Hoek J. Decreasing incidence of PID in Amsterdam. Genitourin Med 1992;68: 353-5.
59. 59 Scholes D, Stergachis A, Heidrich F, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-6.
60. 60 Hillis S, Nakashima A, Amsterdam L, et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plan Perspect 1995;27:108-11.
61. 61 Egger M, Low N, Smith G, et al. Screening for chlamydia infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998;316:1776-80.
62. 62 Paavonen J, Puolakkainen M, Paukku M, et al. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol 1998;92:292-8.
63. 63 Genc M, Mårdh P. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996;124:1-7.
64. 64 Sinei S, Schultz K, Lamptey P, et al. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynaecol 1990;97:412-19.
65. 65 Robinson A, Greenhouse P. Prevention of recurrent pelvic infection by contact tracing: a commonsense approach. Br J Obstet Gynaecol 1996;103:859-61.
66. 66 Simms I, Vickers M, Stephenson J, et al. National assessment of PID diagnosis, treatment and management in general practice: England and Wales. Thirteenth Meeting of the International Society for Sexually Transmitted Diseases Research. Denver, USA, 1999. Abstract No 305
67. 67 Templeton A. The prevention of pelvic infection. London: RCOG Press, 1996.
68. 68 CDC. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 1998;47:1-119.
69. 69 Sellors J, Mahony J, Goldsmith C, et al. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol 1991;164:113-20.
70. 70 Korn A, Hessol N, Padian N, et al. Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis. Sex Transm Dis 1995;22:335-41.
71. 71 Tukeva T, Aronen H, Karjalalnen P, et al. MR imaging in pelvic inflammatory disease: comparison with laparoscopy amd US. Radiology 1999;210:209-16.
72. 72 Hager W, Eschenbach D, Spence M, et al. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983;61: 113-14.
73. 73 Jacobson L, Weström L. Objectivised diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol 1969;105: 1088-98.
74. 74 Hadgu A, Weström L, Brookes C, et al. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol 1986;155:954-60.
75. 75 Rolfs R. "Think PID". Sex Transm Dis 1991;18:131-2.
76. 76 Jossens M, Schachter J, Sweet R. Risk factors associated with pelvic inflammatory disease of differing microbial etiologies. Obstet Gynecol 1994;83:989-97.
77. 77 Kinghorn G, Duerden B, Hafiz S. Clinical and microbiological investigation of women with acute salpingitis and their consorts. Br J Obstet Gynaecol 1986;93:869-80.
78. 78 Stacey C, Munday P, Taylor-Robinson D, et al. A longitutdinal study of pelvic inflammatory disease. Br J Obstet Gynaecol 1992;99:994-9.
79. 79 Paavonen J. Chlamydia trachomatis in acute salpingitis. Am J Obstet Gynecol 1980;138:957-9.
80. 80 Heinonen P, Teisala K, Miettinen A, et al. A comparison of ciprofloxacin with doxycycline plus metronidazole win the treatment of acute pelvic inflammatory disease. Scand J Infect 1989;60:66-73.
81. 81 Paavonen J, Teisala K, Heinonen P, et al. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1987;94:454-60.
82. 82 Ripa KT, Svensson L, Treharne J, et al. Chlamydia trachomatis infection in patients with laparoscopically verified acute salpingitis. Am J Obstet Gynecol 1980;138:960-4.
83. 83 Brihmer C, Kallings I, Nord C-E, et al. Salpingitis: aspects of diagnosis and etiology: a 4-year study from a Swedish capital hospital. Eur J Obstet Gynecol Reprod J Biol 1987;24: 211-20.
84. 84 Soper D, Brockwell N, Dalton H, et al. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994;170:1008-14.
85. 85 Cacciatore B, Leminen A, Ingman-Friberg S, et al. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease. Obstet Gynecol 1992;80:912-16.
86. 86 Wasserheit J, Bell T, Kiviat N, et al. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986;104: 187-93.
87. 87 Kiviat N, Wølner-Hanssen P, Peterson M, et al. Localization of Chlamydia trachomatis infection by direct immunofluorescence and culture in pelvic inflammatory disease. Am J Obstet Gynecol 1986;154:865-73.
88. 88 Livengood C, Hill G, Addison W. Pelvic inflammatory disease: findings during inpatient treatment of clinically severe, laparoscopy-documented disease. Am J Obstet Gynecol 1992;166:519-24.